Development of an intervention to target diabetes device use through an identity framework: ACCPTech (Adapt and Commit to CGM and Pump Technology)
Project Number5K23DK137024-02
Former Number1K23DK137024-01
Contact PI/Project LeaderCOMMISSARIAT, PERSIS
Awardee OrganizationJOSLIN DIABETES CENTER
Description
Abstract Text
Project Summary/Abstract
Diabetes technologies to treat type 1 diabetes (T1D) are rapidly advancing: continuous glucose monitors
(CGMs) provide data on glucose levels and trends throughout the day without the burden of fingersticks;
insulin pumps increase ease of taking insulin without injections; and hybrid closed-loop systems automate
insulin delivery by syncing an insulin pump and CGM through a dosing algorithm to allow for reduced user
responsibilities. However, despite these advances, use of diabetes technologies remains particularly low in
young adults (YAs) with T1D, and many YAs experience suboptimal glucose levels, which places substantial
risks upon their long-term health. YAs report the most common reasons for their avoidance or discontinuation
of diabetes device use include not liking to wear anything on their body, dislike of how the devices looks on
their body, and worries about what others may think. These concerns around personal and social perceptions
intersect a major developmental task of young adulthood: identity development. This K23 application, led by
Dr. Commissariat, proposes to address the potential challenges of technology use by applying a framework of
how YAs “incorporate” T1D into identity (e.g., through stigma management, adjustment to perceived
interference, and benefit-finding) in order to design and evaluate a novel intervention to increase uptake and
sustained use of diabetes technologies. The 3 aims of the proposed project are to: 1) Explore trends of
technology use over time in YAs using electronic health record data; 2) Identify core intervention targets
through qualitative analysis of the intersection between technology and identity; and 3) Create, pilot, and
evaluate the Adapt and Commit to CGM and Pump Technology (ACCPTech) intervention to enhance diabetes
device use in YAs with T1D. The primary outcomes of the ACCPTech pilot RCT are feasibility and
acceptability, and preliminary data will contribute to our understanding of how identity relates to device use,
and whether addressing identity challenges can enhance device use in YAs. These results will inform a future
R01 application of a fully-powered randomized controlled trial to enhance device uptake, use, and subsequent
glycemic and psychosocial outcomes in YAs with T1D. The mentorship, education, training, and resources
outlined in this proposal will support Dr. Commissariat’s career development and her goal to become a
successful, independent behavioral researcher focused on utilizing diabetes identity as a means to improve
diabetes-related management and outcomes in children, adolescents, and young adults with T1D.
Public Health Relevance Statement
PROJECT NARRATIVE
There have been substantial advances in diabetes technologies in recent years, developed in efforts to
improve glycemic outcomes and reduce the burdens of diabetes self-management. However, diabetes device
use remains particularly low in young adults (YAs) with type 1 diabetes (T1D), an age group that most often
reports devices as negatively affecting their self-perception; a timely concern given that identity development
occurs in young adulthood. The current study aims to better understand patterns of diabetes technology use
and the intersection of technology with identity, in an effort to develop, implement, and evaluate an intervention
aimed to enhance diabetes device use within an identity framework, with the ultimate goal of improving the
health and psychosocial outcomes of YAs with T1D.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdolescent and Young AdultAffectAgeAlgorithmsArtificial Endocrine PancreasAttentionAwardBehavioralBody ImageCaringCharacteristicsChildChronic DiseaseContinuous Glucose MonitorDataDedicationsDevelopmentDevicesDiabetes MellitusDoseEducationElectronic Health RecordEnvironmentFeedbackFingersFocus GroupsFoundationsFrightFutureGlucoseGlycosylated hemoglobin AGoalsHealthHybridsInjectionsInsulinInsulin Infusion SystemsInsulin-Dependent Diabetes MellitusInterventionInterviewKnowledgeLengthLifeMentorsMentorshipModelingNeighborhoodsOutcomePatternPersonsProcessPumpRandomized, Controlled TrialsReportingResearch PersonnelResourcesRiskSamplingSelf PerceptionSeriesSocial NetworkSocial PerceptionStatistical Data InterpretationStructureSurveysSystemTechniquesTechnologyTimeTrainingWorkacceptability and feasibilityage groupcareer developmentdesigndiabetes self-managementexperienceglucose monitorglycemic controlimprovedinnovationinsightintervention mappingintervention refinementmultidisciplinarymultilevel analysisnovelpatient orientedprimary outcomepsychosocialpsychosocial outcomerecruitsatisfactionskillssocial health determinantssocial influencesocial stigmasociodemographic factorssociodemographicssocioeconomicsstandard of caretechnology interventiontherapy designtherapy developmenttime usetrenduptakeyoung adult
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
071723084
UEI
UUUMQVGJNNX1
Project Start Date
01-April-2024
Project End Date
31-January-2029
Budget Start Date
01-February-2025
Budget End Date
31-January-2026
Project Funding Information for 2025
Total Funding
$188,784
Direct Costs
$174,800
Indirect Costs
$13,984
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Diabetes and Digestive and Kidney Diseases
$188,784
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K23DK137024-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K23DK137024-02
Patents
No Patents information available for 5K23DK137024-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K23DK137024-02
Clinical Studies
No Clinical Studies information available for 5K23DK137024-02
News and More
Related News Releases
No news release information available for 5K23DK137024-02
History
No Historical information available for 5K23DK137024-02
Similar Projects
No Similar Projects information available for 5K23DK137024-02